60 Degrees Pharmaceuticals, Inc. (SXTP)
NASDAQ: SXTP · Real-Time Price · USD
1.450
-0.020 (-1.36%)
Jun 3, 2026, 10:55 AM EDT - Market open
60 Degrees Pharmaceuticals Employees
60 Degrees Pharmaceuticals had 3 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$438,301
Profits / Employee
-$2,695,344
Market Cap
3.86M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 3 | 0 | - |
| Dec 31, 2024 | 3 | 0 | - |
| Dec 31, 2023 | 3 | 1 | 50.00% |
| Dec 31, 2022 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Virax Biolabs Group | 19 |
| VivoSim Labs | 14 |
| Azitra | 13 |
| Decoy Therapeutics | 11 |
| Revelation Biosciences | 9 |
| Alzamend Neuro | 6 |
| Galmed Pharmaceuticals | 6 |
| Adial Pharmaceuticals | 5 |
SXTP News
- 8 days ago - 60 Degrees announces early enrollment of first patient in trial of tafenoquine - TheFly
- 8 days ago - 60 Degrees Pharmaceuticals Announces Early Enrollment of First Seasonal Patient in Clinical Trial of Tafenoquine for Patients Hospitalized with Babesiosis - GlobeNewsWire
- 13 days ago - H.C. Wainwright downgrades 60 Degrees on ‘untenable’ spending - TheFly
- 13 days ago - 60 Degrees Pharmaceuticals downgraded to Neutral from Buy at H.C. Wainwright - TheFly
- 19 days ago - 60 Degrees Pharmaceuticals Announces First Quarter 2026 Results - GlobeNewsWire
- 19 days ago - 60 Degrees Pharmaceuticals Quarterly report: Q1 2026 - Filings
- 19 days ago - 60 Degrees Pharmaceuticals Earnings release: Q1 2026 - Filings
- 6 weeks ago - 60 Degrees Pharmaceuticals Transcript: Biotech Resurgence: Platforms and Pipelines of Today's Innovators - Transcripts